Gill Capital Partners’s Merck MRK Stock Holding History

Gill Capital Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$98.4K	Buy	766 +340	+80%	+$39.8K	0.03%	213
2026 Q1	$51.2K	Buy	+426	New	+$49.2K	0.01%	262

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Gill Capital Partners's MRK Position: Q2 2026 in Review

Gill Capital Partners increased its Merck (MRK) stake by 80% in Q2 2026, buying an estimated $39.8K and bringing the position to 766 shares worth $98.4K. The position accounts for 0.03% of the portfolio, ranked #213.

Gill Capital Partners first reported a position in MRK in Q1 2026 and has held it in 2 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Gill Capital Partners held 766 shares of Merck worth $98.4K as of Q2 2026.
Gill Capital Partners bought 340 Merck shares in Q2 2026, an estimated $39.8K.
Merck made up 0.03% of Gill Capital Partners's portfolio in Q2 2026, its #213 holding.
Gill Capital Partners first reported a position in Merck in Q1 2026 and has held it in 2 quarters since.
3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Gill Capital Partners's 13F filing for Q2 2026, filed 20 Aug 2026.